Search research articles
Contact Us
Filters
Showing results (51-60 of 102) with videos related to
Page
of 11
Sort By:
European Journal of Haematology
|
December 24, 2009
Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma
Martin Kaiser, Britta Lamottke, Maren Mieth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 31, 2009
Epigenetic modulation of radiation response in human cancer cells with activated EGFR or HER-2 signaling: potential role of histone deacetylase 6
In Ah Kim, Mina No, Jang Mi Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3
Purva Bali, Prince George, Pamela Cohen, et al.
Plos One
|
July 17, 2010
Polycomb target genes are silenced in multiple myeloma
Antonia Kalushkova, Mårten Fryknäs, Miguel Lemaire, et al.
The Journal of Pathology
|
April 30, 2009
The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines
Michael B Prystowsky, Alfred Adomako, Richard V Smith, et al.
Melanoma Research
|
August 22, 2013
The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
David M Woods, Karrune Woan, Fengdong Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2012
Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells
Warren Fiskus, Rekha Rao, Ramesh Balusu, et al.
Cell Chemical Biology
|
September 20, 2016
Histone Demethylase LSD1 Promotes Adipocyte Differentiation through Repressing Wnt Signaling
Yan Chen, Jeesun Kim, Ruipeng Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2010
Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells
Rekha Rao, Srilatha Nalluri, Warren Fiskus, et al.
Molecular Cancer Therapeutics
|
April 8, 2010
Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cells
Rekha Rao, Srilatha Nalluri, Ravindra Kolhe, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 102) with videos related to
Sort By:
Page
of 11
European Journal of Haematology
|
December 24, 2009
Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma
Martin Kaiser, Britta Lamottke, Maren Mieth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 31, 2009
Epigenetic modulation of radiation response in human cancer cells with activated EGFR or HER-2 signaling: potential role of histone deacetylase 6
In Ah Kim, Mina No, Jang Mi Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3
Purva Bali, Prince George, Pamela Cohen, et al.
Plos One
|
July 17, 2010
Polycomb target genes are silenced in multiple myeloma
Antonia Kalushkova, Mårten Fryknäs, Miguel Lemaire, et al.
The Journal of Pathology
|
April 30, 2009
The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines
Michael B Prystowsky, Alfred Adomako, Richard V Smith, et al.
Melanoma Research
|
August 22, 2013
The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
David M Woods, Karrune Woan, Fengdong Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2012
Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells
Warren Fiskus, Rekha Rao, Ramesh Balusu, et al.
Cell Chemical Biology
|
September 20, 2016
Histone Demethylase LSD1 Promotes Adipocyte Differentiation through Repressing Wnt Signaling
Yan Chen, Jeesun Kim, Ruipeng Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2010
Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells
Rekha Rao, Srilatha Nalluri, Warren Fiskus, et al.
Molecular Cancer Therapeutics
|
April 8, 2010
Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cells
Rekha Rao, Srilatha Nalluri, Ravindra Kolhe, et al.
Page
of 11